Camurus AB

Camurus AB

- Medical Nanoparticles Technology

From

0

FluidCrysta nanoparticles can resolve bioavailability issues for water and lipid-soluble pharmaceuticals or biodegradation-sensitive drugs, such as peptides and proteins. FluidCrystal nanoparticles are usually water-based and comprise a stable emulsion of nanoparticles with a liquid crystalline structure. Investigational medicinal products based on this technology are administered either parenterally via injections, or as a liquid sprayed onto the skin or mucous membranes.

Key Attributes

  • Prolonged systemic drug circulation (parenteral administration)
  • Enhanced delivery over mucosal and skin surfaces (topical administration)
  • Protection of sensitive drug substances
  • High solubilization capacity of drug substances
  • Good systemic and local tolerability demonstrated in pre-clinical and clinical trials

Customer reviews

No reviews were found for Camurus FluidCrystal - Medical Nanoparticles Technology. Be the first to review!